Decision-Making in Transplant Candidate Selection Committees: Frameworks and Other Considerations.

Organ transplant selection committees are tasked with deciding whether patients seeking a transplant are medically and psychosocially appropriate to be placed on the waitlist. The selection process is obscure to patients and those outside of the institution. Currently, very limited standards exist for decision-making in selection committees, which could exacerbate inequities and disparities in the transplant process, a major concern among patients.

Financial Toxicity in Early Phase Oncology Clinical Trials: A Review and Ethical Analysis.

Of the many burdens cancer patients face, the impact on personal finances is often invisible to clinicians. Financial toxicity refers to the negative impact on patients' and families' quality of life due to a combination of high out-of-pocket costs of medical treatment, diminished savings, and psychological distress as a result of diminished finances. Financial toxicity in cancer care has been more closely examined in the standard-of-care setting.

Professional Quality of Life and Turnover Intention in Forensic Nurse Program Coordinators: Implications to Forensic Nurse Workforce Development.

Background: Significant barriers to forensic nurse workforce development exist, affecting patient care access. Retention of forensic nurses is a persistent problem, and turnover of forensic nurses can be attributed to many factors related to professional quality of life, including compassion satisfaction (CS), burnout (BO), and secondary traumatic stress (STS).

Purpose: The aim of this study was to identify the effect of an educational session on the topic of professional quality of life and strategies for mitigating the impact of stressors within the forensic nurse role on Professional Quality of Life Scale-5 and Turnover Intention Scale-6.

The Faces of Financial Toxicity: A Qualitative Interview Study of Financial Toxicity in Advanced Cancer Patients in Phase I Oncology Trials.

Objective: To characterize the financial toxicity experienced by advanced cancer patients enrolled in phase I oncology trials.

Patients And Methods: We conducted structured interviews with cancer patients participating in phase I clinical trials. Using a thematic analysis approach, we identified recurring themes in patients' experiences of financial toxicity resulting from trial participation.